IP Library › Granted Patent US 12,397,107
Granted Patent B2
US 12,397,107 · App. 18/629,246 · Granted Aug 26, 2025

Syringe adapter

Inventors: George Mansour (Diamond Bar, CA); Linda Ewing (San Clemente, CA); Eugene Mason (La Habra Heights, CA); Tomas Frausto (Walnut, CA); Ryan Callahan (Long Beach, CA)
Assignee: CAREFUSION 303, INC.
A61M5/162A61J1/2065A61M39/12A61M2039/1072A61M2039/1077
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,397,107
App. No.
18/629,246
Granted
Aug 26, 2025
Kind
B2
Abstract

A syringe adapter includes a female connector, a body in fluid communication with the female connector, a male connector in fluid communication with the female connector and the body, a passage extending radially through the body and a cannula extending axially through the body and out through the female connector, a first end of the cannula fluidly coupled to an end of the passage disposed within the body. A filter housing containing a filter is fluidly coupled to an end of the passage that is exterior to the body, the filter housing terminating in a vent that is fluidly coupled to the passage. A first fluid path is formed through the cannula, the passage and the vent, and a second fluid path is formed through the female connector, the body, and the male connector, wherein a closed system is provided when the male connector is uncoupled from the medical device.

Claims (33)

1. A syringe adapter for coupling a syringe to a fluid system, the syringe adapter comprising:

a female connector;

a body in fluid communication with the female connector;

a male connector in fluid communication with the female connector and the body, the male connector configured to couple with a medical device;

a passage extending radially through the body;

a cannula extending axially through the body and out through the female connector, a first end of the cannula fluidly coupled to an end of the passage disposed within the body;

a filter housing fluidly coupled to an end of the passage that is exterior to the body, the filter housing terminating in a vent that is fluidly coupled to the passage; and

a filter disposed in the filter housing,

wherein a first fluid path is formed through the cannula, the passage and the vent, and a second fluid path is formed through the female connector, the body, and the male connector, and wherein a closed system is provided when the male connector is uncoupled from the medical device.

2. The syringe adapter of claim 1 , further comprising a valve disposed in the filter housing between the filter and the passage.

3. The syringe adapter of claim 2 , wherein the valve is configured to allow ambient air to flow from the vent to the passage via the filter.

4. The syringe adapter of claim 2 , wherein the valve is configured to prevent fluid from flowing from the passage to the filter.

5. The syringe adapter of claim 1 , wherein the filter housing is elevated with respect to the female connector.

6. The syringe adapter of claim 1 , wherein the filter housing is angled with respect to the passage and extends axially away from the male connector.

7. The syringe adapter of claim 1 , wherein the filter housing extends axially beyond the female connector.

8. The syringe adapter of claim 1 , wherein the female connector is coupled to the syringe such that a second end of the cannula is arranged within a chamber of the syringe.

9. The syringe adapter of claim 1 , wherein the medical device is an intravenous set.

10. The syringe adapter of claim 1 , wherein the medical device is a needle-free connector.

11. A syringe adapter for coupling with a syringe, the syringe adapter comprising:

a housing;

a needle-free connector disposed in the housing;

a communication member in slidable engagement with the housing, the communication member slidable, with respect to the housing, between an unactuated state and an actuated state of the syringe adapter;

a cannula extending from the communication member, wherein, in the unactuated state, the cannula is retracted within the needle-free connector and, in the actuated state, the cannula protrudes through and axially beyond the needle-free connector; and

a conduit extending from, and disposed through, the communication member, wherein the conduit is fluidly separated from the needle-free connector when the syringe adapter is coupled with the syringe and in the unactuated state.

12. The syringe adapter of claim 11 , wherein the conduit is in fluid communication with the needle-free connector when the syringe adapter is coupled with the syringe and in the actuated state.

13. The syringe adapter of claim 12 , further comprising a duct extending from, and through, the communication member, wherein the duct fluidly couples the cannula to at least one vent disposed in a filter housing.

14. The syringe adapter of claim 13 , further comprising a filter disposed in the filter housing and a valve disposed between the filter and the cannula, wherein the valve is configured to allow fluid to flow from the at least one vent through the filter to the cannula and is configured to prevent fluid flow from the cannula to the filter.

15. The syringe adapter of claim 14 , further comprising a first fluid path and a second fluid path when the syringe adapter is coupled to the syringe and in the actuated state.

16. The syringe adapter of claim 15 , wherein the first fluid path is configured to provide filtered ambient air into the syringe and the second fluid path is configured to allow fluid from the syringe to flow to an intravenous set coupled to the syringe adapter.

17. The syringe adapter of claim 16 , wherein the first fluid path flows through at least the cannula, the duct, and the at least one vent.

18. The syringe adapter of claim 16 , further comprising a piston element disposed in the needle-free connector, the piston element comprising a piston head and a sealable orifice disposed through the piston head, wherein the sealable orifice is in a sealed state when the piston element is in an uncompressed state and is in an opened state when the piston element is in a compressed state.

19. The syringe adapter of claim 18 , wherein the needle-free connector comprises a connection port sealingly flush with the piston head and the sealable orifice when the syringe adapter is uncoupled with the syringe.

20. The syringe adapter of claim 19 , wherein the second fluid path flows through at least the connection port, the piston element, and the conduit.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2024
From: MANSOUR, GEORGE; EWING, LINDA; MASON, EUGENE; FRAUSTO, TOMAS; CALLAHAN, RYAN
To: CAREFUSION 303, INC.
Reel/Frame 067036/0127 →
Continuity (3)
Continuation 17674639 · Feb 17, 2022
Continuation 16158179 · Oct 11, 2018
Related Publication 20240252746A1 · Aug 1, 2024
References Cited (26)
US 4623343A · Thompson · 1986 [cited by applicant]
US 8647310B2 · Fangrow, Jr. · 2014 [cited by applicant]
US 11285261B2 · Mansour et al. · 2022 [cited by applicant]
US 20040138626A1 · Cote, Sr. · 2004 [cited by applicant]
US 20060142735A1 · Whitley · 2006 [cited by examiner]
US 20070112323A1 · Daly · 2007 [cited by applicant]
US 20110276035A1 · Fangrow, Jr. et al. · 2011 [cited by applicant]
US 20150032063A1 · Thorne · 2015 [cited by applicant]
US 20160030293A1 · Dorsey et al. · 2016 [cited by applicant]
US 20160250413A1 · Good et al. · 2016 [cited by applicant]
US 20160361504A1 · Kim et al. · 2016 [cited by applicant]
CN 104955507A · 2015 [cited by applicant]
CN 106620925A · 2017 [cited by applicant]
JP H08196628A · 1996 [cited by applicant]
JP 2012521806A · 2012 [cited by applicant]
WO WO2018056465 · 2018 [cited by applicant]
Australian Office Action for Application No. 2019357891, dated Apr. 16, 2024, 3 pages. [cited by applicant]
Chinese Office Action for Application No. 201980081464.0, dated Aug. 2, 2022, 13 pages including translation. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2019/054098, dated Mar. 17, 2020, 17 pages. [cited by applicant]
Invitation to Pay Additional Fees, Partial Search Report, and Provisional Opinion for International Patent Application No. PCT/US2019/054098, dated Jan. 15, 2020, 12 pages. [cited by applicant]
Japanese Office Action for Application No. 2021-519706, dated Mar. 14, 2023, 6 pages including translation. [cited by applicant]
Japanese Office Action for Application No. 2023-183704, dated Jun. 13, 2024, 6 pages including translation. [cited by applicant]
Extended European Search Report for Application No. 24207472.2, dated Feb. 5, 2025, 9 pages. [cited by applicant]
Canadian Office Action for Application No. 3,115,759, dated Feb. 6, 2025, 5 pages. [cited by applicant]
Chinese Office Action for Application No. 202310280712.2, dated May 13, 2025, 11 pages including translation. [cited by applicant]
Japanese Office Action for Application No. 2024-225926, dated May 1, 2025, 5 pages including translation. [cited by applicant]